{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:14:45Z","timestamp":1780528485925,"version":"3.54.1"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The prevalence of type 2 diabetes (T2DM) at reproductive age is rising. Women with T2DM have a similarly high risk for pregnancy complications as pregnant women with type 1 diabetes. To reduce adverse pregnancy and neonatal outcomes, such as preeclampsia and preterm delivery, a multi-target approach is necessary. Tight glycemic control together with appropriate gestational weight gain, lifestyle measures, and if necessary, antihypertensive treatment and low-dose aspirin is advised. This narrative review discusses the latest evidence on preconception care, management of diabetes-related complications, lifestyle counselling, recommendations on gestational weight gain, pharmacologic treatment and early postpartum management of T2DM.<\/jats:p>","DOI":"10.3389\/fendo.2023.1193271","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T20:27:41Z","timestamp":1689971261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of type 2 diabetes in pregnancy: a narrative review"],"prefix":"10.3389","volume":"14","author":[{"given":"Lore","family":"Raets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ingelbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Benhalima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv060","article-title":"The management of type 1 and type 2 diabetes in pregnancy","volume":"108","author":"Egan","year":"2015","journal-title":"Qjm"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002960","article-title":"201: Pregestational Diabetes Mellitus","volume":"132","author":"Practice Bulletin No","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1109825","article-title":"Glycaemic control and novel technology management strategies in pregestational diabetes mellitus","volume":"13","author":"Newman","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0197-3","article-title":"Improving pregnancy outcomes in women with diabetes mellitus: modern management","volume":"15","author":"Ringholm","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.014","article-title":"Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes","volume":"138","author":"N\u00f8rgaard","year":"2018","journal-title":"Diabetes Res Clin Pr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s42000-020-00192-z","article-title":"Clinical practice guidelines on diabetes mellitus and pregnancy: I. Pre-existing type 1 and type 2 diabetes mellitus","volume":"19","author":"Anastasiou","year":"2020","journal-title":"Hormones"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2019.05.009","article-title":"Type 2 Diabetes in Pregnancy","volume":"48","author":"Kapur","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1071","article-title":"Pregnancy outcomes in young women with youth-onset type 2 diabetes followed in the TODAY study","volume":"45","author":"Group TS","year":"2022","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of diabetes and diabetes-related complications","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.4981","article-title":"Management of Preexisting Diabetes in Pregnancy: A Review","volume":"321","author":"Alexopoulos","year":"2019","journal-title":"Jama"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1267-6","article-title":"Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes","volume":"19","author":"Bianco","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S015","article-title":"15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1113","article-title":"Effectiveness of a Regional Prepregnancy Care Program in Women With Type 1 and Type 2 Diabetes: Benefits beyond glycemic control","volume":"33","author":"Murphy","year":"2010","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1186\/1471-2458-12-792","article-title":"Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Wahabi","year":"2012","journal-title":"BMC Public Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237571","article-title":"Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes","volume":"15","author":"Wahabi","year":"2020","journal-title":"PloS One"},{"key":"B18","volume-title":"Diabetes in pregnancy: management from preconception to the postnatal period","year":"2020"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.02.019","article-title":"A Review of the Pathophysiology and Management of Diabetes in Pregnancy","volume":"95","author":"Egan","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1111\/ajo.13265","article-title":"ADIPS 2020 guideline for pre-existing diabetes and pregnancy","volume":"60","author":"Rudl","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2465","article-title":"Diabetes and pregnancy: An endocrine society clinical practice guideline","volume":"98","author":"Blumer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0904","article-title":"Progression of Diabetic Retinopathy and Predictors of Its Development and Progression During Pregnancy in Patients With Type 1 Diabetes: A Report of 499 Pregnancies","volume":"44","author":"Bourry","year":"2021","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14819","article-title":"Prevalence and severity of diabetic retinopathy in pregnant women with diabetes\u2014time to individualize photo screening frequency","volume":"39","author":"Pappot","year":"2022","journal-title":"Diabetic Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14111","article-title":"Prevalence of diabetic retinopathy in women with pregestational diabetes during pregnancy and the postpartum","volume":"50","author":"Widyaputri","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12760","article-title":"Diabetic retinopathy in pregnancy: a review","volume":"44","author":"Morrison","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.0050","article-title":"Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis","volume":"140","author":"Widyaputri","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.038","article-title":"Diabetes and Pregnancy","volume":"42","author":"Feig","year":"2018","journal-title":"Can J Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00920112","article-title":"Obstetric nephrology: pregnancy in women with diabetic nephropathy\u2013the role of antihypertensive treatment","volume":"7","author":"Mathiesen","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-018-0553-8","article-title":"Pregnancy in women with diabetic nephropathy","volume":"32","author":"Spotti","year":"2019","journal-title":"J Nephrol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1031","article-title":"Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: Prevalence, antihypertensive strategy, and pregnancy outcome","volume":"36","author":"Damm","year":"2013","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-015-0705-3","article-title":"Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding","volume":"16","author":"Ringholm","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1900\/RDS.2013.10.6","article-title":"Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study","volume":"10","author":"Piccoli","year":"2013","journal-title":"Rev Diabetic Stud"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.906577","article-title":"Dietary advices on carbohydrate intake for pregnant women with type 1 diabetes","volume":"28","author":"Roskj\u00e6r","year":"2015","journal-title":"J maternal-fetal neonatal Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/prilozi-2016-0022","article-title":"Maternal Lipids May Predict Fetal Growth in Type 2 Diabetes Mellitus and Gestational Diabetes Mellitus Pregnancies","volume":"37","author":"Krstevska","year":"2016","journal-title":"PRILOZI"},{"key":"B35","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/db15-1061","article-title":"Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes","volume":"65","author":"Cade","year":"2016","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0484","article-title":"Changes in Serum Lipid Levels During Pregnancy in Type 1 and Type 2 Diabetic Subjects","volume":"33","author":"G\u00f6bl","year":"2010","journal-title":"Diabetes Care"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0551","article-title":"Large-for-Gestational-Age Neonates in Type 1 Diabetes and Pregnancy: Contribution of Factors Beyond Hyperglycemia","volume":"41","author":"McGrath","year":"2018","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11892-019-1204-8","article-title":"Exercise in Pregnant Women with Diabetes","volume":"19","author":"Peters","year":"2019","journal-title":"Curr Diabetes Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000592","article-title":"A Pragmatic Approach to the Treatment of Women With Type 2 Diabetes in Pregnancy","volume":"64","author":"Bender","year":"2021","journal-title":"Clin Obstet Gynecol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1571196","article-title":"Type 1 and Type 2 Diabetes Preconception and in Pregnancy: Health Impacts, Influence of Obesity and Lifestyle, and Principles of Management","volume":"34","author":"Abell","year":"2016","journal-title":"Semin Reprod Med"},{"key":"B41","volume-title":"Preexisting Diabetes and Pregnancy","author":"Kitzmiller","year":"2018"},{"key":"B42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/01.ede.0000147122.97061.bb","article-title":"Maternal obesity, gestational diabetes, and central nervous system birth defects","volume":"16","author":"Anderson","year":"2005","journal-title":"Epidemiology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13324","article-title":"Does prepregnancy weight change have an effect on subsequent pregnancy health outcomes? A systematic review and meta-analysis","volume":"23","author":"Nagpal","year":"2022","journal-title":"Obes Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/nu10101479","article-title":"Screening and Management of Gestational Diabetes Mellitus after Bariatric Surgery","volume":"10","author":"Benhalima","year":"2018","journal-title":"Nutrients"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/nu15051244","article-title":"Pregnancy after Bariatric Surgery: Nutrition Recommendations and Glucose Homeostasis: A Point of View on Unresolved Questions","volume":"15","author":"Burlina","year":"2023","journal-title":"Nutrients"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.3390\/jcm9092732","article-title":"Glucose Homeostasis, Fetal Growth and Gestational Diabetes Mellitus in Pregnancy after Bariatric Surgery: A Scoping Review","volume":"9","author":"Deleus","year":"2020","journal-title":"J Clin Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0780-1","article-title":"Innovative clinical pathways for obese pregnant women: design and feasibility of the Padua project (North-Eastern Italy)","volume":"41","author":"Lapolla","year":"2018","journal-title":"J Endocrinological Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/01.aog.0000425667.1037","article-title":"ACOG Committee opinion no. 549: obesity in pregnancy","volume":"121","year":"2013","journal-title":"Obstet Gynaecol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1739512","article-title":"Gestational Weight Gain and Adverse Maternal and Neonatal Outcomes for Pregnancies Complicated by Pregestational and Gestational Diabetes","volume":"39","author":"Kiefer","year":"2022","journal-title":"Am J Perinatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1232","article-title":"Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes","volume":"36","author":"\u00c1sbj\u00f6rnsd\u00f3ttir","year":"2013","journal-title":"Diabetes Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109811","article-title":"Gestational weight gain in women with type 2 diabetes and perinatal outcomes: A secondary analysis of the metformin in women with type 2 diabetes in pregnancy (MiTy) trial","volume":"186","author":"Fu","year":"2022","journal-title":"Diabetes Res Clin Practice"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.17226\/12584","article-title":"Weight gain during pregnancy: reexamining the guidelines","author":"Rasmussen","year":"2009","journal-title":"Weight Gain During Pregnancy: Reexamining the Guidelines"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0896","article-title":"Higher gestational weight gain is associated with increasing offspring birth weight independent of maternal glycemic control in women with type 1 diabetes","volume":"37","author":"Secher","year":"2014","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.3390\/nu14224867","article-title":"Dietary Advice to Support Glycaemic Control and Weight Management in Women with Type 1 Diabetes during Pregnancy and Breastfeeding","volume":"14","author":"Ringholm","year":"2022","journal-title":"Nutrients"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.07.030","article-title":"Evaluating gestational weight gain recommendations in pregestational diabetes","volume":"213","author":"Siegel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3817","article-title":"Ten years of optimizing outcomes for women with type 1 and type 2 diabetes in pregnancy\u2014the Atlantic DIP experience","volume":"101","author":"Owens","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-0040-1714209","article-title":"Pilot Randomized Controlled Trial of Diabetes Group Prenatal Care","volume":"39","author":"Carter","year":"2022","journal-title":"Am J Perinatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2016.1209650","article-title":"Glycemic control, compliance, and satisfaction for diabetic gravidas in centering group care","volume":"30","author":"Parikh","year":"2017","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221094626","article-title":"Effectiveness of Telemedicine in Managing Diabetes in Pregnancy: A Systematic Review and Meta-Analysis","volume":"9","author":"Laursen","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B60","first-page":"A5417","article-title":"Use of the smartphone application \u201cPregnant with Diabetes\u201d","volume":"64","author":"N\u00f8rgaard","year":"2017","journal-title":"Dan Med J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11892-011-0249-0","article-title":"Management of diabetes in pregnancy","volume":"12","author":"Ballas","year":"2012","journal-title":"Curr Diabetes Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.09.011","article-title":"Severe hypoglycemia in pregnant women with type 2 diabetes\u2014A relevant clinical problem","volume":"102","author":"Secher","year":"2013","journal-title":"Diabetes Res Clin Practice"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01880.x","article-title":"Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey","volume":"23","author":"Akram","year":"2006","journal-title":"Diabetic Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/OGX.0b013e31824bb538","article-title":"New technologies for the management of pregestational diabetes mellitus","volume":"67","author":"Lee-Parritz","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2018.09.004","article-title":"The management of pre-existing (type 1 and type 2) diabetes mellitus in pregnancy","volume":"46","author":"Etomi","year":"2018","journal-title":"Med (United Kingdom)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"100465","DOI":"10.1016\/j.conctc.2019.100465","article-title":"Investigating the role of early low-dose aspirin in diabetes: A phase III multicentre double-blinded placebo-controlled randomised trial of aspirin therapy initiated in the first trimester of diabetes pregnancy","volume":"16","author":"Finnegan","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/10641955.2019.1704002","article-title":"Preeclampsia in women with pregestational diabetes - a cohort study","volume":"39","author":"Oppermann","year":"2020","journal-title":"Hypertens Pregnancy"},{"key":"B68","article-title":"NICE committee. National Institute for Health and Care Excellence: Guidelines","volume-title":"Hypertension in pregnancy: diagnosis and management","year":""},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1182","article-title":"Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study","volume":"44","author":"Do","year":"2021","journal-title":"Diabetes Care"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"New Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09846","article-title":"randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women","volume":"103","year":"1996","journal-title":"BJOG an Int J obstetrics gynaecology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"New Engl J Med"},{"key":"B73","article-title":"Preconception management of diabetes","volume":"60","author":"Shearer","year":"2018","journal-title":"Br Columbia Med J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2018.01.002","article-title":"Pregestational Diabetes in Pregnancy","volume":"45","author":"Sugrue","year":"2018","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.39","article-title":"Insulin analogues in type 1 diabetes mellitus: Getting better all the time","volume":"13","author":"Mathieu","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2019.02.005","article-title":"Drugs to Control Diabetes During Pregnancy","volume":"46","author":"Feghali","year":"2019","journal-title":"Clin Perinatol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/151975","article-title":"Comparison of insulin lispro protamine suspension with NPH insulin in pregnant women with type 2 and gestational diabetes mellitus: Maternal and perinatal outcomes","volume":"2013","author":"Colatrella","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3692-3","article-title":"Safety of insulin analogs during pregnancy: a meta-analysis","volume":"292","author":"Lv","year":"2015","journal-title":"Arch Gynecol Obstet."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14461","article-title":"Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis","volume":"23","author":"Avgerinos","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0514-8","article-title":"A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes","volume":"56","author":"Heise","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045650","article-title":"CopenFast trial: Faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation - a randomised controlled trial","volume":"11","author":"N\u00f8rgaard","year":"2021","journal-title":"BMJ Open"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2363-6","article-title":"Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy","volume":"55","author":"Murphy","year":"2012","journal-title":"Diabetologia"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02485.x","article-title":"Perinatal outcomes associated with the use of glargine during pregnancy","volume":"25","author":"Di Cianni","year":"2008","journal-title":"Diabetic Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S2213-8587(22)00307-2","article-title":"Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open\u2212label, multinational, randomised, controlled, non-inferiority trial","volume":"11","author":"Mathiesen","year":"2023","journal-title":"Lancet Diabetes endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2013.03.015","article-title":"Use of oral hypoglycemic and insulin agents in pregnant patients","volume":"33","author":"Feldman","year":"2013","journal-title":"Clin Lab Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13275","article-title":"Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study","volume":"20","author":"Cea-Soriano","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11892-018-1045-x","article-title":"Inpatient Glycemic Management of the Pregnant Patient","volume":"18","author":"Yeh","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/s-0036-1597625","article-title":"Glycemic Control and Pregnancy Outcomes in Women with Type 2 Diabetes Treated with Oral Hypoglycemic Agents","volume":"34","author":"Feghali","year":"2017","journal-title":"Am J Perinatol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15795.1","article-title":"Recent advances in the antepartum management of diabetes","volume":"8","author":"Mitric","year":"2019","journal-title":"F1000Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12376","article-title":"The use of oral hypoglycaemic agents in pregnancy","volume":"31","author":"Holt","year":"2014","journal-title":"Diabetes Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.2015761","article-title":"Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials","volume":"38","author":"Li","year":"2022","journal-title":"Gynecological Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2022RW6155","article-title":"Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis","volume":"20","author":"Oliveira","year":"2022","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12884-018-2108-3","article-title":"Rationale, design, and methods for the Medical Optimization and Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD) study","volume":"18","author":"Berry","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1326994","article-title":"Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial","volume":"30","author":"Hickman","year":"2013","journal-title":"Am J Perinatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-03207-0","article-title":"Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13503","article-title":"The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: A systematic review and meta-analysis of 21 randomized controlled trials","volume":"47","author":"He","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2022-002919","article-title":"Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis","volume":"11","author":"Abolhassani","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707193","article-title":"Metformin versus Insulin for the Treatment of Gestational Diabetes","volume":"358","author":"Rowan","year":"2008","journal-title":"New Engl J Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.03.036","article-title":"Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome","volume":"89","author":"Glueck","year":"2008","journal-title":"Fertil Steril"},{"key":"B102","doi-asserted-by":"publisher","first-page":"325851","DOI":"10.1155\/2015\/325851","article-title":"Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy","volume":"2015","author":"Ainuddin","year":"2015","journal-title":"J Diabetes Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11892-021-01409-0","article-title":"Metformin in Pregnancy for Women with Type 2 Diabetes: a Review","volume":"21","author":"Benham","year":"2021","journal-title":"Curr Diabetes Rep"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0013","article-title":"Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin","volume":"45","author":"Feig","year":"2022","journal-title":"Diabetes Care"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002848","article-title":"Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis","volume":"16","author":"Tarry-Adkins","year":"2019","journal-title":"PloS Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.06.013","article-title":"A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes","volume":"219","author":"Barbour","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S2213-8587(23)00004-9","article-title":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial","volume":"11","author":"Feig","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00034-7","article-title":"Big babies, small babies: metformin exposure in pregnancy","volume":"11","author":"Kusinski","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.127744","article-title":"Glycemic management after antenatal corticosteroid therapy","volume":"6","author":"Kalra","year":"2014","journal-title":"North Am J Med Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14744","article-title":"Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes - an updated guideline from the Joint British Diabetes Society for Inpatient Care","volume":"39","author":"Dashora","year":"2021","journal-title":"Diabetes Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14137","article-title":"Severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes","volume":"37","author":"Yamamoto","year":"2020","journal-title":"Diabetes Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13546","article-title":"Intrapartum glycaemic control and neonatal hypoglycaemia in pregnancies complicated by diabetes: a systematic review","volume":"35","author":"Yamamoto","year":"2018","journal-title":"Diabetes Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bjae.2019.09.008","article-title":"The peripartum management of diabetes","volume":"20","author":"Yap","year":"2020","journal-title":"Bja Education"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2015.04.009","article-title":"Diabetes in pregnancy","volume":"29","author":"McCance","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4943-9","article-title":"Factors associated with stillbirth in women with diabetes","volume":"62","author":"Mackin","year":"2019","journal-title":"Diabetologia"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.971745","article-title":"Role of ultrasound in the management of diabetes in pregnancy","volume":"28","author":"Ahmed","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13761","article-title":"Timing of delivery in women with diabetes: A population-based study","volume":"99","author":"Metcalfe","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.03.014","article-title":"Predictors of emergency cesarean section in women with preexisting diabetes","volume":"248","author":"Fischer","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.beem.2012.11.001","article-title":"Diabetes and oral contraception","volume":"27","author":"Gourdy","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1193271\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T20:27:47Z","timestamp":1689971267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1193271\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":119,"alternative-id":["10.3389\/fendo.2023.1193271"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1193271","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"article-number":"1193271"}}